|
Diabetes Mellitus, Non-Insulin-Dependent
|
0.030 |
Biomarker
|
disease |
BEFREE |
CTRP1 is a novel adipokine associated with T2DM in humans.
|
24827430 |
2014 |
|
Liver diseases
|
0.010 |
Biomarker
|
group |
BEFREE |
CTRP1 in Liver Disease.
|
28212710 |
2017 |
|
Septicemia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
CTRP1 levels were significantly higher in ICU patients with sepsis.
|
31083558 |
2019 |
|
Sepsis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
CTRP1 levels were significantly higher in ICU patients with sepsis.
|
31083558 |
2019 |
|
Cholestasis
|
0.010 |
Biomarker
|
disease |
BEFREE |
CTRP1 correlated strongly with markers of inflammatory response, renal function, liver damage and cholestasis.
|
31083558 |
2019 |
|
Obesity
|
0.020 |
Biomarker
|
disease |
BEFREE |
As CTRP1 was highly expressed in obese subjects as well as up-regulated in hypertensive patients, CTRP1 may be a newly identified molecular link between obesity and hypertension.
|
18171693 |
2008 |
|
Hypertensive disease
|
0.020 |
Biomarker
|
group |
BEFREE |
As CTRP1 was highly expressed in obese subjects as well as up-regulated in hypertensive patients, CTRP1 may be a newly identified molecular link between obesity and hypertension.
|
18171693 |
2008 |
|
Hypertensive disease
|
0.020 |
AlteredExpression
|
group |
LHGDN |
As CTRP1 was highly expressed in obese subjects as well as up-regulated in hypertensive patients, CTRP1 may be a newly identified molecular link between obesity and hypertension.
|
18171693 |
2008 |
|
Coronary Arteriosclerosis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Association of C1q/TNF-related protein-1 (CTRP1) serum levels with coronary artery disease.
|
31081425 |
2019 |
|
Coronary heart disease
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Association of C1q/TNF-related protein-1 (CTRP1) serum levels with coronary artery disease.
|
31081425 |
2019 |
|
Non-alcoholic Fatty Liver Disease
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
At baseline, obesity, the metabolic syndrome, type 2 diabetes, and non-alcoholic fatty liver disease were significantly associated with increased CTRP1 (all p-values ≤0.001).
|
31051410 |
2019 |
|
Obesity
|
0.020 |
Biomarker
|
disease |
BEFREE |
C1q/tumour necrosis factor-related protein 1 (CTRP1) is a new adipokine with multiple vascular and metabolic effects and may modulate the association between obesity and vascular diseases.
|
31198543 |
2019 |
|
Vascular Diseases
|
0.010 |
Biomarker
|
group |
BEFREE |
C1q/tumour necrosis factor-related protein 1 (CTRP1) is a new adipokine with multiple vascular and metabolic effects and may modulate the association between obesity and vascular diseases.
|
31198543 |
2019 |
|
Diabetes Mellitus, Non-Insulin-Dependent
|
0.030 |
Biomarker
|
disease |
BEFREE |
C1qTNF-related protein 1 (CTRP1) is independently associated with type 2 diabetes.
|
28674284 |
2017 |
|
Pre-existing diabetes mellitus, non-insulin-dependent
|
0.010 |
Biomarker
|
disease |
BEFREE |
Elevated CTRP1 Plasma Concentration Is Associated with Sepsis and Pre-Existing Type 2 Diabetes Mellitus in Critically Ill Patients.
|
31083558 |
2019 |
|
Mucocutaneous Lymph Node Syndrome
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Furthermore, serum CTRP1 levels were positively correlated with the time point of intravenous immunoglobulin (IVIG), WBC, N%, TNF-α, IL-1β, and IL-6 levels in the KD-CAL group.ConclusionCTRP1 may participate in the process of vasculitis and blood coagulation during the acute phase of KD.
|
29360808 |
2018 |
|
Vasculitis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Furthermore, serum CTRP1 levels were positively correlated with the time point of intravenous immunoglobulin (IVIG), WBC, N%, TNF-α, IL-1β, and IL-6 levels in the KD-CAL group.ConclusionCTRP1 may participate in the process of vasculitis and blood coagulation during the acute phase of KD.
|
29360808 |
2018 |
|
Non-alcoholic Fatty Liver Disease
|
0.020 |
Biomarker
|
disease |
BEFREE |
Hence, various roles in metabolic pathways can link CTRP1 to NAFLD pathogenesis.
|
28212710 |
2017 |
|
Kidney Diseases
|
0.010 |
AlteredExpression
|
group |
BEFREE |
High CTRP1 levels may have a renal protective role since they were associated with slower kidney disease progression.
|
31198543 |
2019 |
|
Adult Glioblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Identification of CTRP1 as a Prognostic Biomarker and Oncogene in Human Glioblastoma.
|
31183364 |
2019 |
|
Childhood Glioblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Identification of CTRP1 as a Prognostic Biomarker and Oncogene in Human Glioblastoma.
|
31183364 |
2019 |
|
Arteriosclerosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Inhibition of CTRP1 may inhibit the pathogenesis of atherosclerosis at early stage.
|
28625919 |
2017 |
|
Atherosclerosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Inhibition of CTRP1 may inhibit the pathogenesis of atherosclerosis at early stage.
|
28625919 |
2017 |
|
Dehydration
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
Mice lacking Ctrp1 fail to maintain normotension under dehydration conditions, resulting in hypotension, suggesting that CTRP1 is an essential protein for maintaining blood pressure homeostasis.
|
30463644 |
2018 |
|
Tumor Progression
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
Moreover, CTRP1 knockdown inhibited CCL2 expression, and CCL2 overexpression reversed the inhibition of cell proliferation and migration induced by CTRP1 knockdown, suggesting that CTRP1 promoted tumor progression by regulating CCL2 expression.
|
31183364 |
2019 |